TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform
S-195396 · ENERGY, DEPARTMENT OF
A PHARMACEUTICAL PREPARATION MANUFACTURING solicitation, performed in Los Alamos, NM, with responses due 2026-12-04. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
This technology from scientists at Los Alamos National Laboratory represents a novel platform for improving the safety and effectiveness of therapeutic gas-based treatments by enabling controlled, localized delivery at the site of disease. By addressing longstanding challenges associated with system
Comparable recent awards in PHARMACEUTICAL PREPARATION MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| THERACOM, L.L.C. | $38K | 1 | 2026-07-02 |
| REGIMED MEDICAL | $293K | 7 | 2026-07-02 |
| SRI INTERNATIONAL | $49.9M | 7 | 2026-07-02 |
| PRIORITY HEALTHCARE DISTRIBUTION INC | $16K | 1 | 2026-07-02 |
| COVERMYMEDS PHARMACY LLC | $16K | 1 | 2026-07-02 |
Questions
What is solicitation S-195396?
TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform, issued by ENERGY, DEPARTMENT OF, under NAICS 325412 (PHARMACEUTICAL PREPARATION MANUFACTURING), performed in Los Alamos, NM. Responses are due 2026-12-04.
What do similar contracts close for?
Comparable closed awards in this category ran from $16K to $49.9M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Is S-195396 set aside?
NONE. Check the notice on SAM.gov for the eligibility language that governs.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.